Clinical Trial: Efficacy, Safety, and Pharmacokinetics of Response-Guided Sequential Triazole Therapy Following Liposomal Amphotericin B for Invasive Fungal Disease: A Prospective Cohort Study (China)

Posted On: 2026-08-26

China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy, Safety, and Pharmacokinetics of Response-Guided Sequential Triazole Therapy Following Liposomal Amphotericin B for Invasive Fungal Disease: A Prospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130801

Registration Time: 2026/08/25

Type: Interventional study

Primary Sponsor: Tianjin Integrated Traditional Chinese and Western Medicine Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338194

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy, Safety, and Pharmacokinetics of Response-Guided Sequential Triazole Therapy Following Liposomal Amphotericin B for Invasive Fungal Disease: A Prospective Cohort Study (China)